VIOXX and cardiovascular events: a class effect?
Berenbaum
Francis
F
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D013450:Sulfones / Q000009:adverse effects*
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib